Japan Tissue Engineering Co., Ltd.
7774
Rank in Stocks
#17307
Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine... Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine sector in Japan. The company's activities are organized into three core divisions: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It manufactures and delivers autologous cultured tissues, such as epidermis, cartilage, corneal epithelium, and oral mucosal epithelium, to medical institutions for therapeutic applications. The firm also produces other advanced tissue-engineered medical products. Furthermore, Japan Tissue Engineering is involved in the research and development of three-dimensional human cultured tissue models, which are utilized in the development of external-use cosmetics and drugs, as well as for scientific investigations concerning skin and corneal tissues. Additionally, the company provides comprehensive contract development and manufacturing services for regenerative medicine. Established in 1999, Japan Tissue Engineering Co., Ltd. is based in Gamagori, Japan, and functions as a subsidiary of Teijin Limited.
Share Price
$4.27
Last synced: 2026-11-10
Market Cap
$173.51M
Change (1 day)
6.47%
Change (1 year)
37.14%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Japan Tissue Engineering Co., Ltd. (7774)
Category
Healthcare
EPS for Japan Tissue Engineering Co., Ltd. (7774)
EPS as of September 2026 TTM: $-0.06
According to Japan Tissue Engineering Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.06. At the end of 2025 the company had an EPS of $-0.04, a decrease compared to its 2024 EPS of $0.02.
EPS history for Japan Tissue Engineering Co., Ltd. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.06 | 40.00% |
| 2025 | $-0.04 | -280.26% |
| 2024 | $0.02 | -117.22% |
| 2023 | $-0.14 | 34.36% |
| 2022 | $-0.10 | -2.89% |
| 2021 | $-0.10 | 57.60% |
| 2020 | $-0.07 | -11.08% |
| 2019 | $-0.07 | -240.15% |
| 2018 | $0.05 | -13.58% |
| 2017 | $0.06 | -140.95% |
| 2016 | $-0.15 | -1.71% |
| 2015 | $-0.15 | -30.53% |
| 2014 | $-0.22 | -30.12% |
| 2013 | $-0.31 | -13.48% |
| 2012 | $-0.36 | -27.94% |
| 2011 | $-0.50 | -13.28% |
| 2010 | $-0.58 | 1.46% |
| 2009 | $-0.57 | -13.06% |
| 2008 | $-0.66 | 16.57% |
| 2007 | $-0.56 | 31.86% |
| 2006 | $-0.43 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -28,064.29% |
US
|
|
| $-7.07 | 12,525.00% |
US
|
|
| $-5.29 | 9,346.43% |
AU
|
|
| $12.88 | -23,100.18% |
BE
|
|
| $21.56 | -38,600.00% |
NL
|
Questions about Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS)
What is Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS)?
Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.06, as of Sep 2026.
What was Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS) was $-0.04, compared with $0.02 in 2024.
How has Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS) was highest in 2024 ($0.02) and lowest in 2023 ($-0.14).
How does Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Japan Tissue Engineering Co., Ltd.'s earnings per share (EPS) ($-0.06) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.